India mRNA Synthesis & Manufacturing Market (2024-2029)
The India mRNA Synthesis & Manufacturing Market was valued at $30.85 Million in 2024 and projected to reach to $40.25 Million by 2029, representing a compound annual growth rate of 5.5%. India's mRNA synthesis and manufacturing market is poised for steady expansion, driven by increasing government backing for vaccine production and biotechnology infrastructure development.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
India mRNA Synthesis & Manufacturing Market Trends and Insights
- India is emerging as a critical hub for mRNA production infrastructure, driven by increasing investments in biotechnology capabilities and government support for vaccine manufacturing.
- The market in India reflects growing demand for domestic mRNA-based therapeutics and vaccines, positioning the country as a key player in the Asia Pacific region's biopharmaceutical landscape. The expansion of India's mRNA synthesis and manufacturing sector is underpinned by rising healthcare expenditure, skilled workforce availability, and regulatory framework improvements.
- India's pharmaceutical industry is leveraging its cost-competitive manufacturing advantages to attract global partnerships and contract manufacturing opportunities.
- Between 2024 and 2029, India is expected to strengthen its position in mRNA technology adoption, supported by both public health initiatives and private sector innovation in gene therapy and personalized medicine applications..
Key Market Statistics
- CAGR (2024-2029) 5.5% CAGR
- Market Size, 2024 ~USD 30.85 Million
- Forecast, 2029 ~USD 40.25 Million
- Country India
India mRNA Synthesis & Manufacturing Market Overview
Market Valuation & Growth :
India's mRNA synthesis and manufacturing market is valued at USD 30.85 million in 2024, with a projected CAGR of 5.5% through 2029, reaching USD 40.25 million by forecast end.
Government Support & Infrastructure :
India is leveraging government initiatives and biotechnology investments to establish itself as a critical mRNA production hub, with enhanced manufacturing capabilities and regulatory frameworks supporting vaccine development.
Vaccine Manufacturing Demand :
Growing domestic and export demand for mRNA-based vaccines is driving infrastructure expansion across Indian pharmaceutical and biotech companies, positioning India as a key global supplier.
Emerging Biotech Ecosystem :
India's expanding biotechnology sector, coupled with cost-competitive manufacturing advantages, is attracting foreign partnerships and investments in mRNA synthesis technologies and production facilities.
India mRNA Synthesis & Manufacturing Market Dynamics
- The country's cost-effective manufacturing capabilities and growing scientific expertise position it as an attractive destination for mRNA production investments.
- Domestic pharmaceutical companies are scaling up capabilities to meet both national immunization programs and international vaccine demand, creating significant growth opportunities through 2029. The market outlook remains positive as India strengthens its position in the global mRNA supply chain.
- Strategic partnerships with international biotech firms, combined with regulatory improvements and skilled workforce development, will accelerate market penetration.
- Rising healthcare investments and pandemic preparedness initiatives further support sustained growth in mRNA synthesis and manufacturing capabilities across the Indian biotech landscape..
Related Ecosystem
Advanced Genetic Sequencing
- Polymerase Chain Reaction (PCR)
- Reagents
- Assay Kits
- Bioinformatics
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Danaher Corporation
Analytical And Scientific Instrumentation
- Environmental Testing
- Gas Chromatography
- Polymerase Chain Reaction (PCR)
- Automated Liquid Handling Systems
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- Shimadzu Corporation
- Merck KGaA
Pharmaceuticals
- Bioreactors
- Analytical Testing
- Bioanalytical Testing Services
- Cell Counters
- Data Management Services
- Thermo Fisher Scientific Inc.
- SANOFI
- Merck KGaA
- NOVARTIS
- Pfizer Inc.
Key Takeaways
- India's mRNA synthesis and manufacturing market is valued at USD 30.85 million in 2024, with a projected CAGR of 5.5% through 2029.
- India is positioning itself as a cost-competitive manufacturing hub for mRNA-based therapeutics and vaccines in the Asia Pacific region.
- Government initiatives and increased biotech investments are accelerating India's adoption of mRNA technology and production capabilities.
- India's skilled pharmaceutical workforce and regulatory improvements are attracting global partnerships and contract manufacturing opportunities in mRNA synthesis.
mRNA Synthesis & Manufacturing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | MRNA SYNTHESIS & MODIFICATION SERVICES (Service) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 5.8% from 2024 to 2029 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 2.23 (2024) |
| Revenue Forecast (Billions) | ~USD 2.96 (2029) |
| Segments Covered | Product, Type, Application, End User, Service, Consumables, Transcription Consumables, Purification Consumables, Analysis & Characterization Consumables |
India mRNA Synthesis & Manufacturing Market Report Segmentation
9 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Type
- Analysis & Characterization Consumables
- Analysis Kits And Reagents
- Chromatography Filters & Membrane
- Mrna Profiling Kits
- Mrna Synthesis Kits
- Nucleotides
- Other Products
- Other Purification Consumables
- Other Transcription Consumables
- Plasmid Dna/Dna Templates
- Purification Consumables
- Purification Kits & Reagents
- Rna Polymerases
- Transcription Consumables
- Vectors
By Application
- Cell & Gene Therapies
- Other Applications
- Vaccines
By End User
- Academic & Research Institutions
- Cros & Cdmos
- Cros And Cdmos
- Pharmaceutical & Biotechnology Companies
- Small-Scale Cros & Cdmos
By Service
- Manufacturing & Scale-Up Services
- Mrna Analysis & Characterization Services
- Mrna Purification Services
- Mrna Synthesis & Modification Services
By Consumables
- Analysis & Characterization Consumables
- Purification Consumables
- Transcription Consumables
By Transcription Consumables
- Mrna Profiling Kits
- Mrna Synthesis Kits
- Nucleotides
- Other Transcription Consumables
- Plasmid Dna/Dna Templates
- Rna Polymerases
- Vectors
By Purification Consumables
- Chromatography Filters & Membranes
- Other Purification Consumables
- Purification Kits & Reagents
- Purification Kits And Reagents
By Analysis & Characterization Consumables
- Analysis Kits & Reagents
- Analysis Kits And Reagents
- Other Analysis & Characterization Consumables
INDIA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTIONS | 10.96 | 8.08 | 8.18 | 8.52 | 8.99 | 9.48 | 10 | 10.69 | 5.5 |
| CROS AND CDMOS | 9.25 | 6.81 | 6.89 | 7.17 | 7.56 | 7.97 | 8.41 | 8.98 | 5.4 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 25.85 | 19.09 | 19.36 | 20.19 | 21.35 | 22.56 | 23.84 | 25.52 | 5.7 |
| TOTAL | 46.1 | 34 | 34.4 | 35.9 | 37.9 | 40 | 42.2 | 45.2 | 5.6 |
INDIA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTIONS | 5.6 | 4.9 | 5 | 5.2 | 5.6 | 6 | 6.5 | 7.2 | 7.8 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 16 | 14 | 14.3 | 15 | 16.2 | 17.5 | 19.1 | 21.2 | 8.2 |
| SMALL-SCALE CROS & CDMOS | 1.9 | 1.7 | 1.7 | 1.8 | 1.9 | 2 | 2.2 | 2.4 | 6.9 |
| TOTAL | 23.5 | 20.6 | 20.9 | 22 | 23.6 | 25.5 | 27.8 | 30.8 | 8 |
Target Audience
- Pharmaceutical & Biotech Companies : Indian and multinational pharma firms need market intelligence to assess expansion opportunities, identify acquisition targets, and develop mRNA manufacturing strategies tailored to India's regulatory environment.
- Investment & Private Equity Firms : Investors evaluating India's biotech sector require detailed market data to identify high-growth mRNA companies, assess valuation benchmarks, and make informed capital allocation decisions.
- Government & Policy Makers : Indian government agencies and health ministries use market insights to design biotechnology policies, allocate funding for vaccine manufacturing infrastructure, and support domestic industry development.
- Contract Manufacturing Organizations (CMOs) : CMOs and contract development manufacturers need India-specific market data to understand demand trends, capacity requirements, and competitive positioning in the growing mRNA manufacturing sector.
- Technology & Equipment Suppliers : Suppliers of mRNA synthesis equipment and manufacturing technologies require market intelligence to identify customer opportunities, forecast demand, and develop India-focused sales and support strategies.
Reasons to Buy this Report
- India-Specific Market Sizing : Access precise valuation data for India's mRNA market with verified 2024 baseline (USD 30.85M) and 2029 forecasts, enabling accurate investment planning and resource allocation decisions.
- Competitive Landscape Intelligence : Understand India's unique position in global mRNA manufacturing, including local player capabilities, government support mechanisms, and competitive advantages that differentiate the Indian market.
- Growth Opportunity Identification : Identify high-potential segments within India's mRNA sector, including vaccine manufacturing, contract manufacturing services, and technology partnerships driving the 5.5% CAGR expansion.
- Strategic Partnership Insights : Evaluate partnership and investment opportunities with Indian biotech firms, pharmaceutical companies, and government initiatives supporting mRNA infrastructure development and capacity building.
- Regulatory & Policy Framework : Gain insights into India-specific regulatory pathways, government incentives, and policy support for mRNA manufacturing that impact market entry strategies and operational planning.
Frequently asked questions
What is the current market size of mRNA synthesis and manufacturing in India?
India's mRNA synthesis and manufacturing market was valued at USD 30.85 million in 2024 and is expected to grow to USD 40.25 million by 2029.
What is the projected growth rate for India's mRNA market?
India's mRNA synthesis and manufacturing market is projected to grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2029.
Why is India becoming important in mRNA manufacturing?
India is leveraging its cost-competitive advantages, skilled pharmaceutical workforce, government support for biotech, and regulatory improvements to establish itself as a key mRNA manufacturing hub in Asia Pacific.
What factors are driving growth in India's mRNA market?
Key drivers include rising healthcare expenditure, increased biotech investments, government vaccine manufacturing initiatives, growing demand for mRNA-based therapeutics, and expanding contract manufacturing opportunities in India.
How does India's mRNA market compare to the global market?
While India's market is valued at USD 30.85 million (2024), the global mRNA synthesis and manufacturing market is significantly larger at USD 2.23 billion, reflecting India's emerging but growing role in the sector.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the mRNA synthesis and manufacturing market. Exhaustive secondary research was done to collect information on the mRNA synthesis and manufacturing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as market share analysis, MnM repository analysis, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the mRNA synthesis and manufacturing market.
Secondary Research
The market for the companies offering mRNA synthesis and manufacturing solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product & service portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases. In the secondary research process, various secondary sources were referred to for identifying and collecting information related to the study. Secondary sources included annual reports, press releases, and investor presentations of blockchain vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and product-oriented perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global mRNA synthesis and manufacturing market scenario. Several primary interviews were conducted with market experts from both the demand side (such as personnel from the pharmaceutical & biopharmaceutical industry) and the supply side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, as well as channels) across five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Approximately 80% and 20% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, and online, personal, and telephonic interviews.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Top-down approache was used to estimate and validate the total size of the mRNA synthesis and manufacturing market. These methods include market share analysis, MnM repository analysis were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and market have been identified through extensive secondary research.
- The revenues generated from the mRNA synthesis and manufacturing market business of leading players have been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
Market Definition
mRNA synthesis and manufacturing refers to the process of producing messenger RNA (mRNA) through in vitro transcription, followed by various purification, and characterization steps to create high-quality mRNA products suitable for research, therapeutic, or vaccine applications. The mRNA synthesis and manufacturing market encompasses the development, production, and commercialization of messenger RNA (mRNA) products, including their synthesis via in vitro transcription, large-scale manufacturing, and formulation. This market serves various applications such as vaccines, therapeutic treatments, and potentially other areas like protein replacement. It involves specialized technologies and equipment, adherence to regulatory standards, and a global supply chain network.
The study provides an in-depth analysis of the mRNA synthesis and manufacturing market based on contemporary market trends and developments, and its potential growth from 2024 to 2029. It includes detailed market trends, the competitive landscape, market size, forecasts, and the analysis of the key mRNA synthesis and manufacturing product and service providers.
Stakeholders
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Development and Manufacturing Organizations (CDMOs)
- Raw Material Suppliers
- Market Research and Consulting Firms
- Regulatory Agencies
- Venture Capitalists
- Government Organizations
- Industry Associations and Professional Societies
Report Objectives
- To define, describe, and forecast the mRNA synthesis and manufacturing market based on product, service, application, and region
- To define, describe, and forecast the mRNA synthesis and manufacturing market based on product by end user and service by end user
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the mRNA synthesis and manufacturing market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players in the global mRNA synthesis and manufacturing market and comprehensively analyze their products and services portfolios, market positions, and core competencies.
- To track and analyze competitive developments such as product/service launches, expansions, agreements, and collaborations in the mRNA synthesis and manufacturing market
- To benchmark players within the mRNA synthesis and manufacturing market using the Company Evaluation Matrix framework, which analyzes market players based on various parameters within the broad categories of business and service strategy
Get the Full mRNA Synthesis & Manufacturing Market Report
Full forecast, segment splits, and company analysis for all mRNA Synthesis & Manufacturing Market.
- Canada mRNA Synthesis & Manufacturing Market
- US mRNA Synthesis & Manufacturing Market
- Germany mRNA Synthesis & Manufacturing Market
- UK mRNA Synthesis & Manufacturing Market
- France mRNA Synthesis & Manufacturing Market
- Switzerland mRNA Synthesis & Manufacturing Market
- Italy mRNA Synthesis & Manufacturing Market
- Spain mRNA Synthesis & Manufacturing Market
- China mRNA Synthesis & Manufacturing Market
- Japan mRNA Synthesis & Manufacturing Market
- South Korea mRNA Synthesis & Manufacturing Market
- Brazil mRNA Synthesis & Manufacturing Market
- Rest Of Europe mRNA Synthesis & Manufacturing Market
- Rest Of Asia Pacific mRNA Synthesis & Manufacturing Market
- Rest Of Latin America mRNA Synthesis & Manufacturing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
